Monthly Prescribing Reference

RECELL System Cleared for Skin Repigmentation in Patients With Vitiligo

Credit: Avita Medical. The RECELL System is a single-use, autologous cell harvesting device. The Food and Drug Administration (FDA) has approved the RECELL ® System for the treatment of vitiligo. The ...
Healthline

FDA Approves First At-Home Treatment for Skin Repigmentation in People With Common Type of Vitiligo

Share on Pinterest It’s estimated about 2 million people in the United States have the skin condition vitiligo. FG Trade/Getty Images The first at-home therapy for the most common type of the skin ...
STAT

FDA approves first at-home therapy for skin repigmentation in vitiligo patients

Patients with vitiligo will now have access to the first ever at-home therapy for skin repigmentation approved by the Food and Drug Administration. Jim Lee, vice president for Incyte’s head ...
The American Journal of Managed Care

Ruxolitinib Cream Improves Repigmentation, QOL in Vitiligo, but Better Patient Education, Guidance Are Needed

Ruxolitinib cream can meaningfully improve skin repigmentation and QOL for patients with vitiligo, but its full benefit depends on improved patient education, guidance, and support for consistent, ...
The American Journal of Managed Care

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox

Melanocyte melanin synthesis creates constitutive ROS vulnerability, and impaired Nrf2-mediated antioxidant responses enable ...
Business Wire

Pivotal Phase 3 Data Showing Significant Improvements in Facial and Total Body Repigmentation with Ruxolitinib Cream (Opzelura™) in Vitiligo Published in New England Journal ...

Data served as basis for recent FDA approval of ruxolitinib cream (Opzelura™) 1.5% for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older ...
Seeking Alpha

AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients

VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and ...
Healio

RECELL system efficacious in vitiligo repigmentation

Please provide your email address to receive an email when new articles are posted on . Melanocyte-keratinocyte transplant procedures are rare in the U.S. due to a need for specialized equipment. The ...
Healio

Surgical intervention may yield adequate repigmentation rate in refractory stable vitiligo

Please provide your email address to receive an email when new articles are posted on . More than half of patients undergoing surgical procedures for refractory stable vitiligo experienced more than ...
Medscape

JAK Inhibitor Plus nbUVB Boosts Vitiligo Repigmentation

For patients with active nonsegmental vitiligo, treatment often requires a multifaceted approach to achieve meaningful repigmentation. In a recently published phase 2b extension study, adding ...
BioWorld

Avita’s Recell gains FDA greenlight for skin repigmentation in vitiligo

In its second approval this month from the U.S. FDA, Avita Medical Inc.’s Recell system received premarket approval for the repigmentation of stable depigmented vitiligo lesions. The approval marks ...